Results 141 to 150 of about 6,570 (168)

A Randomised-Controlled Study Demonstrates That Diet Can Contribute to the Clinical Management of Feline Atopic Skin Syndrome (FASS). [PDF]

Animals (Basel)
Watson A, Laxalde J, Brément T, Drevon-Gaillot EV, Mosca M, Maina E, Langon X.   +6 more
europepmc   +1 more source

Evaluation of an indirect Na_V1.7 inhibitor as adjunctive analgesic in burn-related neuropathic pain in a cat. [PDF]

Vet Anaesth Analg
Chiavaccini L, Santoro D, Dwyer CE, Vettorato E, Nelson TS, Khanna R.   +5 more
europepmc   +1 more source

DERMATOLOGÍA: La terramicina en el tratamiento de las enfermedades de la piel [PDF]

, 1952
Reiss Dale, Frederick
core  

A prospective study evaluating the correlation between local weather conditions, pollen counts and pruritus of dogs with atopic dermatitis. [PDF]

Vet Dermatol
Widorn L, Zabolotski Y, Mueller RS.
europepmc   +1 more source

Costo per NNT di upadacitinib nel trattamento dei pazienti con dermatite atopica da moderata a severa in Italia. [PDF]

Glob Reg Health Technol Assess
Chiricozzi A, Costanzo A, Levi A, Parretta F, Ravasio R.   +4 more
europepmc   +1 more source

Allergen immunotherapy in Italy: How, when, and why-A real-world study conducted through a patient association. [PDF]

World Allergy Organ J
Paoletti G, Nappi E, Bragato MC, Valli P, Giovannini M, Gargano D, Pecoraro L, Diso D, Barbaglia S, Canonica GW, Heffler E.   +10 more
europepmc   +1 more source

ALERGIA: Algunos principios y problemas básicos de alergia [PDF]

Simón, Frank A.
core  

Some of the next articles are maybe not open access.

Related searches:

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial

Lancet, The, 2022
Kilian Eyerich, Fernando Valenzuela
exaly  

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2021
Kristian Reich, Marjolein de Bruin-Weller, Thomas Bieber   +2 more
exaly